Michael S. Fenster, MD FACC, FSCA&I, FRSM, MIANE, PEMBA

Trump tariffs on imports and effects on health care, explained

The Weight Loss Drug Revolution: GLP-1 RA drugs inspire new excitement for metabolic bariatric surgeons

The Weight Loss Drug Revolution: Helping patients avoid phony medicine scams

Scientists, senators spar over NIH money, research, diseases that affect millions

AMA’s new medical education policies aim to reduce burnout, streamline training and support physician-led care

Real-world use of GLP-1 drugs show lower weight loss in new a new study; new AMA policy to reduce breast cancer risk; a guideline on lifestyle intervention for diabetes care – Morning Medical Update